Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2006 Dec 15;194(12):1737–1744. doi: 10.1086/509260

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2006 by the Infectious Diseases Society of America. All rights reserved.

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 5. — Preincubation of parvovirus B19 (B19)–contaminated platelets with amotosalen as measured by preamplification polymerase chain reaction (PCR) and enzyme‐linked immunospot (ELISpot) assays. A, The log inhibition of B19‐infected platelet concentrates with increasing exposure time to amotosalen before UV A light (UVA) treatment. The preamplification PCR log inhibition results were averaged from results using 3‐ and 5‐kb preamplification amplicons. The same samples were subjected to ELISpot to measure log reductions in infectivity. B, The strong correlation between the preamplification PCR and ELISpot assay as represented by direct plotting of results from both assays.